The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insur Regulatory News (SBRE)

Share Price Information for Sabre Insur (SBRE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 155.20
Bid: 153.80
Ask: 154.40
Change: -0.20 (-0.13%)
Spread: 0.60 (0.39%)
Open: 155.40
High: 155.40
Low: 153.60
Prev. Close: 155.40
SBRE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

21 May 2020 07:00

RNS Number : 5410N
Sabre Insurance Group PLC
21 May 2020
 

 

21 May 2020

SABRE INSURANCE GROUP PLC

 

Trading Update

 

Sabre Insurance Group plc (the "Group" or "Sabre"), one of the UK's leading private motor insurance underwriters, today provides an update on trading for the period ending 31 March 2020 ahead of its AGM later this morning.

¾ Continued focus on strategy of prioritising underwriting profitability over volume.

¾ Overall trading conditions consistent with the update given with the full year results presentation of 7 April 2020.

¾ Gross written premium for the 3 months to 31 March 2020 down approximately 5% year-on-year (£43.7m V £45.9m).

¾ Continued strong organic capital generation with a solvency coverage ratio of 186% (as at 31 March 2020, post payment of 2019 full year dividend), exceeding our preferred range of 140 to 160%.

¾ Premium outturn for the year hard to forecast precisely due to the fast-changing COVID-19 impacted rating environment.

¾ Combined ratio for the financial year is expected to be within the target range of 70 to 80%.

¾ Introduced price decreases for new and renewal business from mid-April to support customers and to reflect lower claims frequency.

¾ All colleagues remain on full salaries and we continue to support our smaller suppliers and customers.

 

Geoff Carter, Chief Executive Officer of Sabre, commented:

"Throughout the COVID-19 crisis, the health and wellbeing of our colleagues and customers has remained our number one priority. Almost all of our people remain working from home, and we are building a robust plan for people to return to the office as and when it is safe for them to do so. Our customers have been able to rely on consistently high-quality levels of service, while we have taken a sympathetic and pragmatic approach to those who are facing financial difficulty and unexpected changes in their lifestyles.

Overall trading conditions are consistent with the update given recently with the full year results on 7 April, albeit in a turbulent market with continued uncertainty caused by the on-going COVID-19 crisis.

Premium volumes continue to be extremely volatile, driven both by consumer behaviour and competitor pricing activity. At the end of March our premium year-on-year was down by around 5% as we sought to enhance our margin by moving lower in our combined operating ratio target corridor and the initial impacts of COVID-19 emerged. Since late March, as the full social distancing measures impacted, we estimate that new business quotations in the market have been down by up to 25% on a weekly basis compared to 2019, primarily driven by the lack of car sales. At the end of April, year to date premiums were down around 15%, although we have seen an improvement in premium levels as May has progressed.

We have continued to see claims frequency reduce significantly throughout late March and April, although traffic does appear to be returning to the roads. From late April we introduced price decreases for new and renewal business following detailed analysis. In addition to supporting customers these reductions reflect the lower costs due to reduced miles driven, whilst ensuring we continue to cover long-term claims and other cost inflation, and the potential for increased frequency and severity of claims as the social distancing measures are eased. Consequently, we have seen an increase in the premiums written in recent weeks - starting to reverse the trend seen in April.

With market volatility expected to continue at least until the current social distancing measures start to ease, and probably for several months thereafter, it remains difficult to forecast the full-year premium outcome with any certainty at this stage. However, we are confident that the year-on-year reduction in premium written reflects the temporary and unique market conditions and volatility. To that end, we will continue to execute our strategy of maintaining underwriting discipline, treating the top line as an output not a target. We believe this will ensure Sabre will be well positioned for growth at the appropriate time. We remain confident our combined operating ratio for the year will fall within our target corridor - although it will be some time before we can be confident exactly where - as claims costs potentially rebound as lockdown eases.

Sabre has a strong balance sheet and a resolute focus on underwriting profitability. The Board remains minded to return excess capital through an additional interim dividend at the appropriate point this year, and is confident of maintaining an attractive dividend for 2020 whilst emerging from this unprecedented period in good shape."

 

Investor enquiries

01306 747 272

Sabre Insurance Group plc

Geoff Carter / Adam Westwood

Media enquiries

020 7353 4200

Tulchan Communications

sabre@tulchangroup.com

James Macey White

David Allchurch

Giles Kernick

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBLGDUUDDDGGG
Date   Source Headline
13th May 202412:23 pmRNSDirector/PDMR Shareholding
23rd Apr 20244:00 pmRNSHolding(s) in Company
22nd Apr 20243:22 pmRNSHolding(s) in Company
19th Apr 20248:51 amRNSChair Appointment
18th Apr 202411:22 amRNSDirector Declaration
11th Apr 202412:41 pmRNSDirector/PDMR Shareholding
11th Apr 202412:07 pmRNSDirector/PDMR Shareholding
9th Apr 20242:44 pmRNSDirector/PDMR Shareholding
5th Apr 20243:48 pmRNSNotice of AGM
21st Mar 202412:30 pmRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSFull-year results 2023
13th Mar 20249:33 amRNSNotice of Results
12th Mar 20242:16 pmRNSDirector/PDMR Shareholding
12th Mar 202412:14 pmRNSDirector Declaration
16th Feb 20241:52 pmRNSHolding(s) in Company
15th Feb 20247:00 amRNSTrading Statement
13th Feb 20242:18 pmRNSDirector/PDMR Shareholding
11th Jan 202411:11 amRNSDirector/PDMR Shareholding
20th Dec 20232:24 pmRNSHolding(s) in Company
12th Dec 202312:03 pmRNSDirector/PDMR Shareholding
28th Nov 20234:27 pmRNSDirectorate Change
27th Nov 20234:42 pmRNSRemuneration Committee Chair Appointment
22nd Nov 20238:51 amRNSNotification of cyber incident
20th Nov 20237:00 amRNSDeath of Chair
13th Nov 202311:44 amRNSDirector/PDMR Shareholding
19th Oct 20237:00 amRNSTrading Update
11th Oct 202312:52 pmRNSDirector/PDMR Shareholding
25th Sep 20233:39 pmRNSDirector/PDMR Shareholding
21st Sep 202311:48 amRNSDirector/PDMR Shareholding
14th Sep 20232:25 pmRNSHolding(s) in Company
13th Sep 202310:00 amRNSDirector/PDMR Shareholding
13th Sep 20239:33 amRNSDirectorate Change
11th Aug 202310:07 amRNSDirector/PDMR Shareholding
3rd Aug 20237:00 amRNSHalf-year Report 2023
25th Jul 20238:53 amRNSDirector Declaration
11th Jul 20232:57 pmRNSDirector/PDMR Shareholding
13th Jun 202310:09 amRNSDirector/PDMR Shareholding
2nd Jun 20233:02 pmRNSDirector/PDMR Shareholding
25th May 202311:22 amRNSResult of AGM
25th May 20239:27 amRNSDirector/PDMR Shareholding
25th May 20237:01 amRNSBoard Appointment
25th May 20237:00 amRNSTrading Update
11th May 202311:42 amRNSDirector/PDMR Shareholding
18th Apr 20233:19 pmRNSDirector/PDMR Shareholding
12th Apr 202311:53 amRNSDirector/PDMR Shareholding
6th Apr 202312:28 pmRNSDirector/PDMR Shareholding
31st Mar 20233:43 pmRNSNotice of AGM
31st Mar 20233:37 pmRNSDirector/PDMR Shareholding
14th Mar 20237:00 amRNSFinal Results
13th Mar 202312:13 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.